Michael G Strainic

Title: Michael G Strainic: Innovator in Growth Factor Modulation

Introduction

Michael G Strainic is a notable inventor based in Westlake, OH (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of growth factor responses. With a total of 5 patents, Strainic's work has implications for treating various disorders.

Latest Patents

Strainic's latest patents include a method for inhibiting platelet-derived growth factor signaling using C3aR or C5aR antibodies. This innovative method involves modulating growth factor responses in cells that express C3a receptor (C3aR) and C5a receptor (C5aR). Another significant patent focuses on compositions and methods for treating T cell-mediated disorders. This method describes generating a CD4FoxP3Treg cell by administering a complement antagonist to naive CD4T cells, effectively inhibiting C3aR and/or C5aR signal transduction.

Career Highlights

Michael G Strainic is affiliated with Case Western Reserve University, where he continues to advance his research and innovation. His work has garnered attention for its potential applications in therapeutic settings.

Collaborations

Strainic collaborates with esteemed colleagues, including M Edward Medof and Feng Lin, contributing to a dynamic research environment.

Conclusion

Michael G Strainic's innovative work in growth factor modulation and T cell-mediated disorders showcases his commitment to advancing biomedical research. His contributions are paving the way for new therapeutic approaches in medicine.